Pacific Biosciences of California, Inc. (PACB)

PACB Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	56.27	63.71	55.37	179.91	325.09	460.73
Short-Term Investments	219.69	215.8	334.56	451.51	447.23	583.68
Cash & Short-Term Investments	275.96	279.51	389.93	631.42	772.32	1,044
Cash Growth	-19.57%	-28.32%	-38.25%	-18.24%	-26.05%	227.59%
Accounts Receivable	29.35	35.45	27.52	36.62	18.79	24.24
Inventory	51.02	49.29	58.76	56.68	50.38	24.6
Other Current Assets	13.18	10.81	19.47	17.34	10.59	7.89
Total Current Assets	369.52	375.05	495.68	742.05	852.07	1,101
Net Property, Plant & Equipment	65.22	65.84	46.6	69.03	81.34	79.12
Other Intangible Assets	14.1	15.12	389.57	456.98	410.25	410.98
Goodwill	317.76	317.76	317.76	462.26	409.97	409.97
Other Long-Term Assets	15.76	10.31	10.84	15.7	13.45	5.76
Total Assets	782.37	784.08	1,260	1,746	1,767	2,007
Accounts Payable	13.61	20.77	16.59	15.06	12.03	11
Accrued Expenses	33.9	33.65	22.6	45.71	32.6	36.26
Current Portion of Leases	0.28	0.45	10.03	9.59	8.89	7.71
Unearned Revenue	16.33	15.94	13.86	16.34	30.5	10.98
Other Current Liabilities	1.24	2.03	3.22	8.33	179.33	5.76
Total Current Liabilities	65.36	72.83	66.3	95.03	263.34	71.71
Long-Term Debt	644.11	645.38	647.49	892.24	896.68	896.07
Long-Term Leases	59	56.59	14.91	31.61	41.07	49.97
Other Long-Term Liabilities	11.53	3.93	25.15	25.83	3.09	198.24
Total Long-Term Liabilities	714.64	705.9	687.55	949.68	940.85	1,144
Total Liabilities	780	778.73	753.85	1,045	1,204	1,216
Common Stock	0.31	0.3	0.29	0.27	0.23	0.22
Additional Paid-in Capital	2,706	2,700	2,655	2,540	2,100	2,010
Accumulated Other Comprehensive Income	-0.15	0.46	0.42	0.22	-4.77	-1.09
Retained Earnings	-2,704	-2,695	-2,149	-1,839	-1,532	-1,218
Shareholders' Equity	2.37	5.35	506.59	701.3	562.9	790.99
Total Liabilities & Equity	782.37	784.08	1,260	1,746	1,767	2,007
Total Debt	703.39	702.42	672.43	933.44	946.64	953.75
Net Cash (Debt)	-427.43	-422.92	-282.5	-302.02	-174.32	90.65
Net Cash Growth	-	-	-	-	-	-67.25%
Net Cash Per Share	-1.41	-1.41	-0.98	-1.19	-0.78	0.44
Book Value	2.37	5.35	506.59	701.3	562.9	790.99
Book Value Per Share	0.01	0.02	1.76	2.77	2.51	3.87
Tangible Book Value	-329.5	-327.54	-200.74	-217.94	-257.32	-29.97
Tangible Book Value Per Share	-1.09	-1.09	-0.70	-0.86	-1.15	-0.15

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q